Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Business Exposures
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
99 100 Next >
Former FDA Agent Says Big Pharma Not Likely To Get Involved In Cannabis Industry After Rescheduling
Via Benzinga
Topics Cannabis
Exposures Cannabis Product Safety
FDA Grants Orphan Drug Designation to Biompharma’s Bi104, a microbiome-modifying biologic, for the treatment of Angelman Syndrome
Via AB Newswire
Exposures Product Safety
Lusk Eye Specialists to Offer OptiLight IPL for Advanced Dry Eye Relief
Via Press Advantage
Exposures Product Safety
PaxMedica Inc. (NASDAQ: PXMD) Announces PAX-101 Batch Completion for NDA Application to FDA
Via Investor Brand Network
Exposures Product Safety
Tickers PXMD
BioMedNewsBreaks — Genprex Inc. (NASDAQ: GNPX) Announces Participation at Upcoming Investor, Industry Events
Via Investor Brand Network
Topics Intellectual Property
Exposures Intellectual Property Product Safety
Tickers GNPX
ZTS LOSS ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Via NewMediaWire
Exposures Product Safety
Tickers ZTS
ZTS LOSS ALERT: ROSEN, A LONGSTANDING LAW FIRM, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Via TheNewswire.com
Exposures Product Safety
Tickers ZTS
Ford Recalls Nearly 243,000 Maverick Trucks Due To Rear Tail Light Concerns
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers F
Poolbeg Pharma and Silk Road Therapeutics announce strategic collaboration on novel orphan drug
Via News Direct
Exposures Product Safety
Poolbeg Pharma and Silk Road Therapeutics announce strategic collaboration on novel orphan drug
Via TheNewswire.com
Topics Intellectual Property
Exposures Intellectual Property Product Safety
InvestorNewsBreaks – Processa Pharmaceuticals Inc. (NASDAQ: PCSA) Appoints Dr. Steven Cha to Lead Clinical Development of Oncology Programs
Via Investor Brand Network
Exposures Product Safety
Tickers PCSA
Top Tesla Rival BYD Recalls Over 16,000 Seagull EVs Over Faulty Reversing Cameras
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers BYDDF BYDDY TSLA
MorphoSys Says Novartis Deal Progressing Steadily Despite Safety Concerns Over Bone Marrow Cancer Drug, Pelabresib
Via Benzinga
Exposures Product Safety
Tickers MOR NVS
FDA Approves X4 Pharmaceuticals' Mavorixafor As First Therapy For Rare Immunodeficiency Disorder
Via Benzinga
Exposures Product Safety
Tickers XFOR
Hemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023
Via News Direct
Exposures Product Safety
Introducing Fana Skin Care bnatural: The Ultimate Medical Grade Black Skin Solution for Radiant, Healthy Glowing Skin
Via Get News
Exposures Product Safety
Hemogenyx Pharmaceuticals outlines significant progress with HEMO-CAR-T in 2023
Via TheNewswire.com
Exposures Product Safety
New Standard of Care? IceCure Submits Final ICE3 Data To FDA, Minimally Invasive Cryoablation Shows Similar 5-year Recurrence Outcomes To Surgery With Hormone Therapy
Via News Direct
Exposures Product Safety
Tickers ICCM
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Via TheNewswire.com
Exposures Product Safety
Tickers ZTS
ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Zoetis Inc. Investors to Inquire About Securities Class Action Investigation - ZTS
Via NewMediaWire
Exposures Product Safety
Tickers ZTS
Canada Cannabis Update: Health Recall, Home Cultivation Ban Reversal, International Expansion
Via Benzinga
Topics Cannabis Product Recall
Exposures Cannabis Legal Product Safety
Tickers CSE:GWAY GWAYF
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via TheNewswire.com
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
ROSEN, A LEADING, LONGSTANDING, AND TOP RANKED FIRM, Encourages bluebird bio Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BLUE
Via NewMediaWire
Topics Lawsuit
Exposures Financial Legal Product Safety
Tickers BLUE
FDA Green Lights Pfizer's Gene Therapy For Rare Bleeding Disorder Hemophilia
Via Benzinga
Exposures Product Safety
Tickers CSLLY PFE
Altria CEO Urges FDA Crackdown On Illicit Vape Products: Report
Via Benzinga
Exposures Product Safety
Tickers HDV MO VTI
Soap Mishap Causes Tesla to Recall Thousands of Cybertrucks
Via Investor Brand Network
Topics Product Recall
Exposures Legal Product Safety
Tickers TSLA
Pfizer Now Rivals The World's Most Expensive Medicine After FDA Approves Gene Therapy
Via Investor's Business Daily
Exposures Product Safety
Tickers PFE QURE
PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (Cboe CA: CYBN) Announces Participation at the 27th Annual Milken Institute Global Conference
Via Investor Brand Network
Exposures Product Safety
Tickers CYBN HLT
Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
Via News Direct
Exposures Product Safety
Petros Pharmaceuticals announces online distribution for lead ED product with Lemonaid Health
Via TheNewswire.com
Exposures Product Safety
< Previous 1 2
...
27 28 29 30 31 32 33 34 35
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.